BIOPORT CORPORATION
UEI MUM1EGCDWZJ4 · Federal customer, award and market-category activity · All available history.Registered entity address in historical award records
Vendor entity location
This is the vendor entity address recorded on its latest historical award action. It is separate from contract place-of-performance geography.
Street address
3500 N MARTIN LUTHER KING JR BLVDCity
LANSINGState or territory
MICHIGANZIP code
489062933Country
UNITED STATESCongressional district
07All available history
Net obligations by year
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2024
2025
2026
Corporate family from historical award records
3 total
Related entities
Connected through ultimate parent EMERGENT BIOSOLUTIONS INC. (UEI DKEFA8JAW3X4). Only entities present in historical award records are included.
| Rank | Entity | UEI | Primary CAGE | CAGE codes | Obligations | Actions | Activity |
|---|---|---|---|---|---|---|---|
| 1 | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | CNPVCR8DK7M8 | 057Y1 | 1 | $450.80M | 26 | 2023–2026 |
| 2 | EMERGENT BIOSOLUTIONS CANADA INC | XM23STFMVML6 | L0EM2 | 1 | $232.55M | 9 | 2025–2026 |
| 3 | EMERGENT BIODEFENSE OPERATIONS LANSING LLC | MUM1EGCDWZJ4 | 1H0B6 | 1 | $63.34M | 11 | 2024–2026 |
Customer concentration
5 totalBuying agencies
| Rank | Agency | Code | Obligations | Actions | Share |
|---|---|---|---|---|---|
| 1 | CENTERS FOR DISEASE CONTROL AND PREVENTION | 7523 | $2.20B | 66 | 57.1% |
| 2 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | 7505 | $1.20B | 74 | 31.0% |
| 3 | DEPT OF THE ARMY | 2100 | $440.96M | 100 | 11.4% |
| 4 | STATE, DEPARTMENT OF | 1900 | $17.57M | 2 | 0.5% |
| 5 | DEFENSE CONTRACT MANAGEMENT AGENCY (DCMA) | 9763 | -$90 | 2 | 0.0% |
Entity locations
1 foundCAGE codes associated with this UEI
| CAGE | Recorded name | First seen | Last seen | Obligations | Actions |
|---|---|---|---|---|---|
| 1H0B6 | EMERGENT BIODEFENSE OPERATIONS LANSING LLC | Dec 1, 2010 | Apr 10, 2026 | $741.69M | 57 |
Market categories
8 totalNAICS industries
| Rank | NAICS | Description | Obligations | Actions | Share |
|---|---|---|---|---|---|
| 1 | 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $3.19B | 113 | 82.7% |
| 2 | 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $213.11M | 28 | 5.5% |
| 3 | 621511 | MEDICAL LABORATORIES | $85.57M | 23 | 2.2% |
| 4 | 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | $80.90M | 12 | 2.1% |
| 5 | 611110 | ELEMENTARY AND SECONDARY SCHOOLS | $39.56M | 8 | 1.0% |
| 6 | 541710 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES | $18.49M | 2 | 0.5% |
| 7 | 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $138.7K | 3 | 0.0% |
| 8 | 541380 | TESTING LABORATORIES | $127.5K | 2 | 0.0% |
Market categories
6 totalProduct & service codes
| Rank | PSC | Description | Obligations | Actions | Share |
|---|---|---|---|---|---|
| 1 | 6505 | DRUGS AND BIOLOGICALS | $3.52B | 205 | 91.2% |
| 2 | AN11 | BIOMEDICAL (BASIC) | $122.74M | 4 | 3.2% |
| 3 | C118 | RESEARCH AND DEVELOPMENT FACILITIES | $113.17M | 27 | 2.9% |
| 4 | AN13 | R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) | $99.94M | 1 | 2.6% |
| 5 | AZ11 | R&D-OTHER R & D-B RES | $2.39M | 1 | 0.1% |
| 6 | Q301 | MEDICAL- LABORATORY TESTING | $339.5K | 6 | 0.0% |
Latest activity
39 total
